ACP-GBDT: An improved anticancer peptide identification method with gradient boosting decision tree
Cancer is one of the most dangerous diseases in the world, killing millions of people every year. Drugs composed of anticancer peptides have been used to treat cancer with low side effects in recent years. Therefore, identifying anticancer peptides has become a focus of research. In this study, an i...
Main Authors: | Yanjuan Li, Di Ma, Dong Chen, Yu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1165765/full |
Similar Items
-
ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation
by: Xian-gan Chen, et al.
Published: (2021-06-01) -
ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides
by: Sadik Bhattarai, et al.
Published: (2022-10-01) -
EnACP: An Ensemble Learning Model for Identification of Anticancer Peptides
by: Ruiquan Ge, et al.
Published: (2020-07-01) -
CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model
by: Huiqing Wang, et al.
Published: (2021-10-01) -
ACP-DRL: an anticancer peptides recognition method based on deep representation learning
by: Xiaofang Xu, et al.
Published: (2024-04-01)